NEW YORK (TheStreet) -- CHANGE IN RATINGS
Anadarko Petroleum (APC) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $83 price target. Tronox litigation will likely hang over the stock.
AOL (AOL) upgraded to hold at TheStreet Ratings.
Broadcom (BRCM) upgraded at Auriga from Hold to Buy, Auriga said. $44 price target. Newer WiFi products should help drive near-term growth.CSX (CSX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Earnings will be hurt by lower coal volume. Itron (ITRI) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse. Valuation call, based on a $50 price target. KLA-Tencor (KLAC) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is already pricing in higher expected spending in the first half of 2012. Life Technologies (LIFE) upgraded at Citigroup from Neutral to Buy, Citigroup said. $56 price target. Friday's drop creates positive risk reward. Lam Research (LRCX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, as the company is already pricing in higher near-term demand. Allscripts (MDRX) downgraded at Leerink from Outperform to Market Perform, Leerink Swann said. Company will struggle to sustain recent bookings growth. Norfolk Southern (NSC) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Company is leveraged to lower coal demand. Oracle (ORCL) downgraded at JMP from Outperform to Market Perform, JMP Securities said. Estimates also cut, as the company may struggle to grow in a cloud computing environment. Pentair (PNR) added to TPL List at Citigroup to Top Picks Live! at Citigroup. $45 price target. Resi is the new late cycle sentiment. Unum (UNM) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Pricing trends are improving and the company may buy back more stock. Web.com Group (WWWW) upgraded to hold at TheStreet Ratings.
STOCK COMMENTS / EPS CHANGESAmerigroup (AGP) numbers raised at Oppenheimer. Shares of AGP now seen reaching $85, according to Oppenheimer. Estimates also increased on solid 4Q results. Outperform rating. Cree (CREE) estimates, target increased at Sterne Agee. CREE estimates were raised through 2013, Sterne Agee said. Company is seeing higher sales and better operating leverage. Buy rating and new $40 price target.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV